Design
Other
Authors
Loading...
Hypothesizes NO as EDRF active principle; leaves open its molecular validation and vascular therapeutic potential.
Key points are not available for this paper at this time.
А. Ф. Ванин (1991) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: